SEC acts against 2 issues
Capital market regulator, Securities and Exchange Commission has decided to investigate the 'abnormal price rise' of Pharma Aids and Chittagong Vegetable shares.
bdnews24.com News Service
bdnews24.com
Published :
31 Oct 2010, 02:38 PM
Updated :
24 Apr 2022, 05:45 PM
Dhaka, Oct 31 (bdnews24.com) — Capital market regulator, Securities and Exchange Commission has decided to investigate the 'abnormal price rise' of Pharma Aids and Chittagong Vegetable shares.
The market watchdog has also decided to halt trading of Pharma Aids until further notice, SEC executive director Anwarul Kabir Bhuiyan said on Sunday after a meeting of the commission.
Pharma Aids recently declared 500 percent profit against its shares.
In response, the issue went up by Tk 11,616.25 from previous sessions' closing price with the share price reaching Tk 25,000 at one point of the day.
The company listed under pharmaceuticals shot up by 162.29 percent and closed at Tk 18,580.
The market regulator has formed a two-member investigation committee to see if the company is really in a position to declare such a level of profit.
The committee has been asked to file a report within seven working days.
The investigation committee has also been asked to identify the investors of Pharma Aids shares on Sunday, especially those who bought the share despite the high price.
SEC spokesperson told the media that the market regulator would also check lists of buyers of Chittagong Vegetable shares over the last month.
The commission has asked the Dhaka Stock Exchange (DSE) to send the details of investors of Chittagong Vegetable.
This company, listed as a 'Z' category issue, saw a rise of 30.49 percent and closed at Tk 2,490.25 on Sunday.
The issue has a net asset worth of Tk 115.45 against each share according to the last financial statement and the company's earnings per share is high.
Chittagong Vegetable shares went up by Tk 590.75 during the day.
The SEC executive director also told the media that the commission has decided to ask for explanation from the DSE why it had not taken any steps in the wake of 'abnormal price rise' of Pharma Aids shares.
bdnews24.com/aam/ta/2030h